Skip to content

a clinical trial to study effect of repetitive transcranial magnetic stimulation in gait and behavioral changes patients with progressive supranuclear gaze palsy

Effect of rTMS on motor and nonmotor symptoms of progressive surpanuclear plasy : Randomised controlled study - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/069987
Enrollment
86
Registered
2024-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system Health Condition 2: G231- Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

Interventions

Intervention1: repetitive transcranial nerve stimulation: 2 sets of 5 daily sessions 1 month apart with coil positioned 3 cm lateral to inion , 1 cm inferior to lateral cerebellum. 20 trains of 10 bu

Sponsors

dr deepika Joshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: probable or possible PSP defined by MDS criteria ability to stand unassisted for 30 seconds and ability to walk independently with walker MMSE 18 or more on stable treatment of anticholinergic, dopaminergic , serotonergic sedative or NMDA receptor antagonist

Exclusion criteria

Exclusion criteria: history of cerebellar ataxia, subdural hematoma, space occupying lesion, hydrocephalus prior vestibular disease sensory deficit in feet epilepsy and psychotic disorder active intake of antiseizure medication pregnancy presence of electrically, magnetically active implants or metal exposures that preclude use of rTMS

Design outcomes

Primary

MeasureTime frame
to study efficacy in motor and nonmotor symptoms after cerebellar rTMS in progressive supranuclear palsy compared to sham procedure with parameters like PSP rating scale MDS non motor rating scale UPDRS part III PSP CDS MOCA FABTimepoint: patient will be assessed at the time of enrollment, at 1 month and at 6 months

Secondary

MeasureTime frame
to look for non motor and behavioral changes in patients with PSPTimepoint: patient will be assessed at the time of enrollment, at 1 month and at 6 months

Countries

India

Contacts

Public ContactDr Deepika Joshi

IMS, BHU, varanasi

jnkmakani@gmail.com9099889038

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026